BF
ELV icon

Brogan Financial’s Elevance Health ELV Stock Holding History

Brogan Financial’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$673K Buy
1,741
+37
+2% +$13.7K 0.27% 22
2026
Q1 		$499K Buy
1,704
+10
+0.6% +$3.29K 0.22% 27
2025
Q4 		$594K Buy
1,694
+8
+0.5% +$2.7K 0.26% 23
2025
Q3 		$545K Buy
1,686
+9
+0.5% +$2.8K 0.23% 27
2025
Q2 		$652K Buy
1,677
+7
+0.4% +$2.82K 0.29% 19
2025
Q1 		$726K Buy
1,670
+7
+0.4% +$2.81K 0.35% 16
2024
Q4 		$613K Buy
1,663
+7
+0.4% +$2.93K 0.3% 15
2024
Q3 		$861K Buy
1,656
+6
+0.4% +$3.21K 0.49% 13
2024
Q2 		$894K Buy
1,650
+5
+0.3% +$2.64K 0.56% 12
2024
Q1 		$853K Buy
1,645
+5
+0.3% +$2.49K 0.56% 13
2023
Q4 		$773K Buy
1,640
+5
+0.3% +$2.31K 0.57% 12
2023
Q3 		$712K Hold
1,635
– – 0.63% 11
2023
Q2 		$726K Hold
1,635
– – 0.62% 11
2023
Q1 		$752K Hold
1,635
– – 0.65% 10
2022
Q4 		$839K Buy
+1,635
New +$830K 0.75% 8

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brogan Financial's ELV Position: Q2 2026 in Review

Brogan Financial increased its Elevance Health (ELV) stake by 2.2% in Q2 2026, buying an estimated $13.7K and bringing the position to 1,741 shares worth $673K. The position accounts for 0.27% of the portfolio, ranked #22.

Brogan Financial first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. The position peaked at $894K in Q2 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Brogan Financial held 1,741 shares of Elevance Health worth $673K as of Q2 2026.
  • Brogan Financial bought 37 Elevance Health shares in Q2 2026, an estimated $13.7K.
  • Elevance Health made up 0.27% of Brogan Financial's portfolio in Q2 2026, its #22 holding.
  • Brogan Financial first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
  • Brogan Financial's Elevance Health position peaked at $894K in Q2 2024.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Brogan Financial's 13F filing for Q2 2026, filed 13 Aug 2026.